{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T18:46:52Z","timestamp":1771872412186,"version":"3.50.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10944-y","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T13:21:39Z","timestamp":1756819299000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the role of HIF-1\u03b1 in pathogenesis of parkinson\u2019s disease and its potential as a therapeutic target"],"prefix":"10.1007","volume":"52","author":[{"given":"Navpreet","family":"Kaur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2450-2975","authenticated-orcid":false,"given":"Khadga Raj","family":"Aran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"issue":"4","key":"10944_CR1","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s00044-024-03203-5","volume":"33","author":"N Saini","year":"2024","unstructured":"Saini N, Singh N, Kaur N, Garg S, Kaur M, Kumar A, Verma M, Singh K, Sohal HS (2024) Motor and non-motor symptoms, drugs, and their mode of action in parkinson\u2019s disease (PD): a review. Med Chem Res 33(4):580\u2013599. https:\/\/doi.org\/10.1007\/s00044-024-03203-5","journal-title":"Med Chem Res"},{"issue":"s1","key":"10944_CR2","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.3233\/JAD-201074","volume":"82","author":"A Merelli","year":"2021","unstructured":"Merelli A, Repetto M, Lazarowski A, Auzmendi J (2021) Hypoxia, oxidative stress, and inflammation: three faces of neurodegenerative diseases J. Alzheimer\u2019s Dis 82(s1):S109\u2013S126. https:\/\/doi.org\/10.3233\/JAD-201074","journal-title":"Alzheimer\u2019s Dis"},{"key":"10944_CR3","doi-asserted-by":"publisher","first-page":"919343","DOI":"10.3389\/fnagi.2022.919343","volume":"14","author":"M Guo","year":"2022","unstructured":"Guo M, Ji X, Liu J (2022) Hypoxia and alpha-Synuclein: inextricable link underlying the pathologic progression of parkinson\u2019s disease. Front Aging Neurosci 14:919343. https:\/\/doi.org\/10.3389\/fnagi.2022.919343","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"10944_CR4","doi-asserted-by":"publisher","first-page":"910","DOI":"10.3390\/brainsci13060910","volume":"13","author":"D Jage\u010di\u0107","year":"2023","unstructured":"Jage\u010di\u0107 D, Petrovi\u0107 DJ, \u0160imuni\u0107 I, Isakovi\u0107 J, Mitre\u010di\u0107 D (2023) The oxygen and glucose deprivation of immature cells of the nervous system exerts distinct effects on mitochondria, mitophagy, and autophagy, depending on the cells\u2019 differentiation stage. Brain Sci 13(6):910. https:\/\/doi.org\/10.3390\/brainsci13060910","journal-title":"Brain Sci"},{"key":"10944_CR5","doi-asserted-by":"publisher","first-page":"237","DOI":"10.33745\/ijzi.2022.v08i02.030","volume":"8","author":"S Diptendu","year":"2022","unstructured":"Diptendu S, Dev MG, Basha KA, Kumar RT, Jahirhussain G, Sarasa D (2022) Reactive oxygen species effects on mitochondrial dynamicity that May lead to parkinson\u2019s disease: A review. Int J Zool Invest 8:237\u2013244. https:\/\/doi.org\/10.33745\/ijzi.2022.v08i02.030","journal-title":"Int J Zool Invest"},{"issue":"6","key":"10944_CR6","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/cbf.2985","volume":"31","author":"AB Zepeda","year":"2013","unstructured":"Zepeda AB, Pessoa A Jr, Castillo RL, Figueroa CA, Pulgar VM, Far\u00edas JG (2013) Cellular and molecular mechanisms in the hypoxic tissue: role of HIF-1 and ROS. Cell Biochem Funct 31(6):451\u2013459. https:\/\/doi.org\/10.1002\/cbf.2985","journal-title":"Cell Biochem Funct"},{"issue":"9","key":"10944_CR7","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.2174\/1570159X19666210729123137","volume":"20","author":"H Chen","year":"2022","unstructured":"Chen H, Ma D, Yue F, Qi Y, Dou M, Cui L, Xing Y (2022) The potential role of hypoxia-inducible factor-1 in the progression and therapy of central nervous system diseases. Curr Neuropharmacol 20(9):1651\u20131666. https:\/\/doi.org\/10.2174\/1570159X19666210729123137","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"10944_CR8","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s10072-024-07832-x","volume":"46","author":"C Wang","year":"2025","unstructured":"Wang C, Lv S, Zhao H, He G, Liang H, Chen K, Qu M, He Y, Ou C (2025) Hypoxia-inducible factor-1 as targets for neuroprotection: from ferroptosis to parkinson\u2019s disease. Neurol Sci 46(3):1111\u20131120. https:\/\/doi.org\/10.1007\/s10072-024-07832-x","journal-title":"Neurol Sci"},{"issue":"19","key":"10944_CR9","doi-asserted-by":"publisher","first-page":"7377","DOI":"10.1523\/JNEUROSCI.20-19-07377.2000","volume":"20","author":"L Studer","year":"2000","unstructured":"Studer L, Csete M, Lee SH, Kabbani N, Walikonis J, Wold B, McKay R (2000) Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in Lowered oxygen. J Neurosci 20(19):7377\u20137383. https:\/\/doi.org\/10.1523\/JNEUROSCI.20-19-07377.2000","journal-title":"J Neurosci"},{"issue":"2","key":"10944_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.canlet.2007.08.009","volume":"257","author":"W Wei","year":"2007","unstructured":"Wei W, Yu XD (2007) Hypoxia-inducible factors: crosstalk between their protein stability and protein degradation. Cancer Lett 257(2):145\u2013156. https:\/\/doi.org\/10.1016\/j.canlet.2007.08.009","journal-title":"Cancer Lett"},{"key":"10944_CR11","doi-asserted-by":"publisher","unstructured":"Semenza GL (2011) Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning. Biochim. Biophys. Acta - Mol Cell Res 71263\u20131268. https:\/\/doi.org\/10.1016\/j.bbamcr.2010.08.006","DOI":"10.1016\/j.bbamcr.2010.08.006"},{"issue":"2","key":"10944_CR12","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.3390\/ijms24021436","volume":"24","author":"D Lin","year":"2023","unstructured":"Lin D, Zhang H, Zhang J, Huang K, Chen Y, Jing X, Tao E (2023) \u03b1-Synuclein induces neuroinflammation injury through the IL6ST-AS\/STAT3\/HIF-1\u03b1 axis. Int J Mol Sci 24(2):1436","journal-title":"Int J Mol Sci"},{"issue":"6b","key":"10944_CR13","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1111\/j.1582-4934.2009.00860.x","volume":"14","author":"MB Herrera","year":"2010","unstructured":"Herrera MB, Fonsato V, Gatti S, Deregibus MC, Sordi A, Cantarella D, Calogero R, Bussolati B, Tetta C, Camussi G (2010) Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J Cell Mol Med 14(6b):1605\u20131618. https:\/\/doi.org\/10.1111\/j.1582-4934.2009.00860.x","journal-title":"J Cell Mol Med"},{"issue":"3","key":"10944_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1365-2141.2008.07029.x","volume":"141","author":"TG Smith","year":"2008","unstructured":"Smith TG, Robbins PA, Ratcliffe PJ (2008) The human side of hypoxia-inducible factor. Br J Haematol 141(3):325\u2013334. https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07029.x","journal-title":"Br J Haematol"},{"issue":"6\u20137","key":"10944_CR15","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.bbabio.2010.02.011","volume":"1797","author":"G Solaini","year":"2010","unstructured":"Solaini G, Baracca A, Lenaz G, Sgarbi G (2010) Hypoxia and mitochondrial oxidative metabolism. BBA Bioenergetics 1797(6\u20137):1171\u20131177. https:\/\/doi.org\/10.1016\/j.bbabio.2010.02.011","journal-title":"BBA Bioenergetics"},{"issue":"5","key":"10944_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41580-020-0227-y","volume":"21","author":"P Lee","year":"2020","unstructured":"Lee P, Chandel NS, Simon MC (2020) Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat Rev Mol Cell Biol 21(5):268\u2013283. https:\/\/doi.org\/10.1038\/s41580-020-0227-y","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"10944_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.cell.2014.04.052","volume":"158","author":"TJ Yuen","year":"2014","unstructured":"Yuen TJ, Silbereis JC, Griveau A, Chang SM, Daneman R, Fancy SP, Zahed H, Maltepe E, Rowitch DH (2014) Oligodendrocyte-encoded HIF function couples postnatal myelination and white matter angiogenesis. Cell 158(2):383\u2013396. https:\/\/doi.org\/10.1016\/j.cell.2014.04.052","journal-title":"Cell"},{"issue":"2","key":"10944_CR18","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1182\/blood-2008-12-193581","volume":"114","author":"N Skuli","year":"2009","unstructured":"Skuli N, Liu L, Runge A, Wang T, Yuan L, Patel S, Iruela-Arispe L, Simon MC, Keith B, Blood (2009) HEMATOL-AM SOC HEMAT 114(2):469\u2013477. https:\/\/doi.org\/10.1182\/blood-2008-12-193581","journal-title":"HEMATOL-AM SOC HEMAT"},{"issue":"2","key":"10944_CR19","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.3892\/mmr.2015.3689","volume":"12","author":"SL Yang","year":"2015","unstructured":"Yang SL, Wu C, Xiong ZF, Fang X (2015) Progress on hypoxia-inducible factor-3: its structure, gene regulation and biological function. Mol Med Rep 12(2):2411\u20132416. https:\/\/doi.org\/10.3892\/mmr.2015.3689","journal-title":"Mol Med Rep"},{"issue":"5","key":"10944_CR20","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3390\/cells12050798","volume":"12","author":"A Yfantis","year":"2023","unstructured":"Yfantis A, Mylonis I, Chachami G, Nikolaidis M, Amoutzias GD, Paraskeva E, Simos G (2023) Transcriptional response to hypoxia: the role of HIF-1-associated co-regulators. Cells 12(5):798. https:\/\/doi.org\/10.3390\/cells12050798","journal-title":"Cells"},{"issue":"2","key":"10944_CR21","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1215\/S1152851704001115","volume":"7","author":"B Kaur","year":"2005","unstructured":"Kaur B, Khwaja FW, Severson EA, Matheny SL, Brat DJ, Van Meir EG (2005) Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro-Oncol 7(2):134\u2013153. https:\/\/doi.org\/10.1215\/S1152851704001115","journal-title":"Neuro-Oncol"},{"issue":"5","key":"10944_CR22","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ccr.2006.08.026","volume":"10","author":"L Holmquist-Mengelbier","year":"2006","unstructured":"Holmquist-Mengelbier L, Fredlund E, L\u00f6fstedt T, Noguera R, Navarro S, Nilsson H, Pietras A, Vallon-Christersson J, Borg \u00c5, Gradin K, Poellinger L (2006) Recruitment of HIF-1\u03b1 and HIF-2\u03b1 to common target genes is differentially regulated in neuroblastoma: HIF-2\u03b1 promotes an aggressive phenotype. Cancer Cell 10(5):413\u2013423. https:\/\/doi.org\/10.1016\/j.ccr.2006.08.026","journal-title":"Cancer Cell"},{"key":"10944_CR23","doi-asserted-by":"publisher","unstructured":"Schoerg AS (2015) PAG1-a Novel Hypoxia Regulated Gene (Doctoral dissertation, University of Zurich). https:\/\/doi.org\/10.5167\/uzh-110676","DOI":"10.5167\/uzh-110676"},{"issue":"7","key":"10944_CR24","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1080\/17460441.2019.1613370","volume":"14","author":"N Albadari","year":"2019","unstructured":"Albadari N, Deng S, Li W (2019) The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy. Expert Opin Drug Discov 14(7):667\u2013682. https:\/\/doi.org\/10.1080\/17460441.2019.1613370","journal-title":"Expert Opin Drug Discov"},{"issue":"4","key":"10944_CR25","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s10517-018-4207-6","volume":"165","author":"VM Chertok","year":"2018","unstructured":"Chertok VM, Nevzorova VA, Zakharchuk NV (2018) Comparative study of HIF-1\u03b1-and HIF-2\u03b1-immunopositive neurons and capillaries in rat cortex under conditions of tissue hypoxia. Bull Exp Biol Med 165(4):516\u2013520. https:\/\/doi.org\/10.1007\/s10517-018-4207-6","journal-title":"Bull Exp Biol Med"},{"issue":"5556","key":"10944_CR26","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1126\/science.1068592","volume":"295","author":"D Lando","year":"2002","unstructured":"Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML (2002) Asparagine hydroxylation of the HIF transactivation domain: a hypoxic switch. Science 295(5556):858\u2013861. https:\/\/doi.org\/10.1126\/science.1068592","journal-title":"Science"},{"issue":"1","key":"10944_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10409238.2013.838205","volume":"49","author":"VL Dengler","year":"2014","unstructured":"Dengler VL, Galbraith MD, Espinosa JM (2014) Transcriptional regulation by hypoxia inducible factors. Crit Rev Biochem Mol Bio 49(1):1\u20135. https:\/\/doi.org\/10.3109\/10409238.2013.838205","journal-title":"Crit Rev Biochem Mol Bio"},{"key":"10944_CR28","doi-asserted-by":"publisher","unstructured":"Bressan, E., Reed, X., Bansal, V., Hutchins, E., Cobb, M. M., Webb, M. G., \u2026 Blauwendraat,C (2023) The Foundational Data Initiative for Parkinson Disease: Enabling efficient translation from genetic maps to mechanism. Cell Genom3(3). https:\/\/doi.org\/10.1016\/j.xgen.2023.100261","DOI":"10.1016\/j.xgen.2023.100261"},{"key":"10944_CR29","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1007\/s12035-018-1316-1","volume":"56","author":"T Chen","year":"2019","unstructured":"Chen T, Wang Q, Chao D, Xia TC, Sheng S, Li ZR, Zhao JN, Wen GQ, Ding G, Xia Y (2019) \u03b4-Opioid receptor activation attenuates the oligomer formation induced by hypoxia and\/or \u03b1-synuclein overexpression\/mutation through dual signaling pathways. Mol Neurobiol 56:3463\u20133475. https:\/\/doi.org\/10.1007\/s12035-018-1316-1","journal-title":"Mol Neurobiol"},{"issue":"2","key":"10944_CR30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/ncb3295","volume":"18","author":"A Lin","year":"2016","unstructured":"Lin A, Li C, Xing Z, Hu Q, Liang K, Han L, Wang C, Hawke DH, Wang S, Zhang Y, Wei Y (2016) The LINK-A LncRNA activates normoxic HIF1\u03b1 signalling in triple-negative breast cancer. Nat Cell Biol 18(2):213\u2013224. https:\/\/doi.org\/10.1038\/ncb3295","journal-title":"Nat Cell Biol"},{"issue":"4","key":"10944_CR31","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1523\/JNEUROSCI.3117-15.2016","volume":"36","author":"S Rajagopalan","year":"2016","unstructured":"Rajagopalan S, Rane A, Chinta SJ, Andersen JK (2016) Regulation of ATP13A2 via PHD2-HIF1\u03b1 signaling is critical for cellular iron homeostasis: implications for parkinson\u2019s disease. J Neurosci 36(4):1086\u20131095. https:\/\/doi.org\/10.1523\/JNEUROSCI.3117-15.2016","journal-title":"J Neurosci"},{"key":"10944_CR32","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.2147\/CMAR.S172008","volume":"16","author":"H Zheng","year":"2018","unstructured":"Zheng H, Zhou C, Lu X, Liu Q, Liu M, Chen G, Chen W, Wang S, Qiu Y (2018) DJ-1 promotes survival of human colon cancer cells under hypoxia by modulating HIF-1\u03b1 expression through the PI3K-AKT pathway. Cancer Manag Res 16:4615\u20134629. https:\/\/doi.org\/10.2147\/CMAR.S172008","journal-title":"Cancer Manag Res"},{"issue":"1","key":"10944_CR33","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1038\/ncomms5514","volume":"5","author":"R Requejo-Aguilar","year":"2014","unstructured":"Requejo-Aguilar R, Lopez-Fabuel I, Fernandez E, Martins LM, Almeida A, Bola\u00f1os JP (2014) PINK1 deficiency sustains cell proliferation by reprogramming glucose metabolism through HIF1. Nat Commun 5(1):4514. https:\/\/doi.org\/10.1038\/ncomms5514","journal-title":"Nat Commun"},{"issue":"9","key":"10944_CR34","doi-asserted-by":"publisher","first-page":"e1886","DOI":"10.1038\/cddis.2015.243","volume":"6","author":"S Kasai","year":"2015","unstructured":"Kasai S, Torii S, Kakita A, Sogawa K (2015) Inhibitory PAS domain protein is a substrate of PINK1 and parkin and mediates cell death in a parkinson\u2019s disease model. Cell Death Dis 6(9):e1886. https:\/\/doi.org\/10.1038\/cddis.2015.243","journal-title":"Cell Death Dis"},{"key":"10944_CR35","doi-asserted-by":"publisher","first-page":"826193","DOI":"10.3389\/fncel.2022.826193","volume":"16","author":"A Ni","year":"2022","unstructured":"Ni A, Ernst C (2022) Evidence that substantia Nigra Pars compacta dopaminergic neurons are selectively vulnerable to oxidative stress because they are highly metabolically active. Front Cell Neurosci 16:826193","journal-title":"Front Cell Neurosci"},{"key":"10944_CR36","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3389\/fnins.2019.00552","volume":"13","author":"J Ma","year":"2019","unstructured":"Ma J, Gao J, Wang J, Xie A (2019) Prion-like mechanisms in parkinson\u2019s disease. Front Neurosci 13:552. https:\/\/doi.org\/10.3389\/fnins.2019.00552","journal-title":"Front Neurosci"},{"issue":"7","key":"10944_CR37","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1021\/acschemneuro.1c00028","volume":"12","author":"S He","year":"2021","unstructured":"He S, Wang F, Yung KK, Zhang S, Qu S (2021) Effects of \u03b1-synuclein-associated post-translational modifications in parkinson\u2019s disease. ACS Chem Neurosci 12(7):1061\u20131071. https:\/\/doi.org\/10.1021\/acschemneuro.1c00028","journal-title":"ACS Chem Neurosci"},{"issue":"2","key":"10944_CR38","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/cns.14055","volume":"29","author":"M Guo","year":"2023","unstructured":"Guo M, Liu W, Luo H, Shao Q, Li Y, Gu Y, Guan Y, Ma W, Chen M, Yang H, Ji X (2023) Hypoxic stress accelerates the propagation of pathological alpha-synuclein and degeneration of dopaminergic neurons. CNS Neurosci Ther 29(2):544\u2013558. https:\/\/doi.org\/10.1111\/cns.14055","journal-title":"CNS Neurosci Ther"},{"issue":"5","key":"10944_CR39","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.cmet.2019.09.016","volume":"30","author":"X Zhang","year":"2019","unstructured":"Zhang X, Zhang Y, Wang P, Zhang SY, Dong Y, Zeng G, Yan Y, Sun L, Wu Q, Liu H, Liu B (2019) Adipocyte hypoxia-inducible factor 2\u03b1 suppresses atherosclerosis by promoting adipose ceramide catabolism. Cell Metab 30(5):937\u2013951. https:\/\/doi.org\/10.1016\/j.cmet.2019.09.016","journal-title":"Cell Metab"},{"issue":"19","key":"10944_CR40","doi-asserted-by":"publisher","first-page":"6963","DOI":"10.1523\/JNEUROSCI.6513-10.2011","volume":"31","author":"KW Lee","year":"2011","unstructured":"Lee KW, Chen W, Junn E, Im JY, Grosso H, Sonsalla PK, Feng X, Ray N, Fernandez JR, Chao Y, Masliah E (2011) Enhanced phosphatase activity attenuates \u03b1-synucleinopathy in a mouse model. J Neurosci 31(19):6963\u20136971. https:\/\/doi.org\/10.1523\/JNEUROSCI.6513-10.2011","journal-title":"J Neurosci"},{"issue":"1","key":"10944_CR41","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41420-022-01260-6","volume":"8","author":"G Li","year":"2022","unstructured":"Li G, Liu J, Guo M, Gu Y, Guan Y, Shao Q, Ma W, Ji X (2022) Chronic hypoxia leads to cognitive impairment by promoting HIF-2\u03b1-mediated ceramide catabolism and alpha-synuclein hyperphosphorylation. Cell Death Discov 8(1):473. https:\/\/doi.org\/10.1038\/s41420-022-01260-6","journal-title":"Cell Death Discov"},{"key":"10944_CR42","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.expneurol.2014.02.022","volume":"255","author":"T Chen","year":"2014","unstructured":"Chen T, Li J, Chao D, Sandhu HK, Liao X, Zhao J, Wen G, Xia Y (2014) \u03b4-Opioid receptor activation reduces \u03b1-synuclein overexpression and oligomer formation induced by MPP\u2009+\u2009and\/or hypoxia. Exp Neurol 255:127\u2013136. https:\/\/doi.org\/10.1016\/j.expneurol.2014.02.022","journal-title":"Exp Neurol"},{"issue":"1","key":"10944_CR43","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.neuron.2010.12.004","volume":"69","author":"T Sasaki","year":"2011","unstructured":"Sasaki T, Takemori H, Yagita Y, Terasaki Y, Uebi T, Horike N, Takagi H, Susumu T, Teraoka H, Kusano KI, Hatano O (2011) SIK2 is a key regulator for neuronal survival after ischemia via TORC1-CREB. Neuron 69(1):106\u2013119. https:\/\/doi.org\/10.1016\/j.neuron.2010.12.004","journal-title":"Neuron"},{"issue":"4","key":"10944_CR44","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/acn3.756","volume":"6","author":"HL Sun","year":"2019","unstructured":"Sun HL, Sun BL, Chen DW, Chen Y, Li WW, Xu MY, Shen YY, Xu ZQ, Wang YJ, Bu XL (2019) Plasma \u03b1-synuclein levels are increased in patients with obstructive sleep apnea syndrome. Ann Clin Transl Neurol 6(4):788\u2013794. https:\/\/doi.org\/10.1002\/acn3.756","journal-title":"Ann Clin Transl Neurol"},{"key":"10944_CR45","doi-asserted-by":"publisher","unstructured":"Guo, M., Liu, W., Luo, H., Shao, Q., Li, Y., Gu, Y., \u2026 Liu, J (2023) Hypoxic stress accelerates the propagation of pathological alpha-synuclein and degeneration of dopaminergic neurons. CNS Neurosci. Ther29(2):544\u2013558. https:\/\/doi.org\/10.1111\/cns.14055","DOI":"10.1111\/cns.14055"},{"issue":"3","key":"10944_CR46","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/jcbfm.2010.170","volume":"31","author":"I Unal-Cevik","year":"2011","unstructured":"Unal-Cevik I, Gursoy-Ozdemir Y, Yemisci M, Lule S, Gurer G, Can A, M\u00fcller V, Kahle PJ, Dalkara T (2011) Alpha-synuclein aggregation induced by brief ischemia negatively impacts neuronal survival in vivo: a study in [A30P] alpha-synuclein Transgenic mouse J. Cereb. Blood Flow Metab 31(3):913\u2013923. https:\/\/doi.org\/10.1038\/jcbfm.2010.170","journal-title":"Blood Flow Metab"},{"issue":"12","key":"10944_CR47","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1111\/1440-1681.13162","volume":"46","author":"EA Kandil","year":"2019","unstructured":"Kandil EA, Sayed RH, Ahmed LA, Abd El Fattah MA, El-Sayeh BM (2019) Hypoxia\u2010inducible factor 1 alpha and nuclear\u2010related receptor 1 as targets for neuroprotection by albendazole in a rat rotenone model of parkinson\u2019s disease. Clin Exp Pharmacol Physiol 46(12):1141\u20131150. https:\/\/doi.org\/10.1111\/1440-1681.13162","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10944_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43042-020-00056-6","volume":"21","author":"ZS Ulhaq","year":"2020","unstructured":"Ulhaq ZS, Garcia CP (2020) Inflammation-related gene polymorphisms associated with parkinson\u2019s disease: an updated meta-analysis. Egypt J Med Hum Genet 21:1\u20130. https:\/\/doi.org\/10.1186\/s43042-020-00056-6","journal-title":"Egypt J Med Hum Genet"},{"issue":"7701","key":"10944_CR49","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-018-0023-4","volume":"556","author":"AC Wendeln","year":"2018","unstructured":"Wendeln AC, Degenhardt K, Kaurani L, Gertig M, Ulas T, Jain G, Wagner J, H\u00e4sler LM, Wild K, Skodras A, Blank T (2018) Innate immune memory in the brain shapes neurological disease hallmarks. Nature 556(7701):332\u2013338. https:\/\/doi.org\/10.1038\/s41586-018-0023-4","journal-title":"Nature"},{"issue":"4","key":"10944_CR50","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3233\/JPD-130250","volume":"3","author":"GT Kannarkat","year":"2013","unstructured":"Kannarkat GT, Boss JM, Tansey MG (2013) The role of innate and adaptive immunity in parkinson\u2019s disease. J Parkinson\u2019s Dis 3(4):493\u2013514. https:\/\/doi.org\/10.3233\/JPD-130250","journal-title":"J Parkinson\u2019s Dis"},{"issue":"8","key":"10944_CR51","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/nn.4338","volume":"19","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM (2016) A polarizing question: do M1 and M2 microglia exist? Nat Neurosci 19(8):987\u2013991. https:\/\/doi.org\/10.1038\/nn.4338","journal-title":"Nat Neurosci"},{"key":"10944_CR52","doi-asserted-by":"publisher","unstructured":"Paolicelli, R. C., Sierra, A., Stevens, B., Tremblay, M. E., Aguzzi, A., Ajami, B.,\u2026 Wyss-Coray, T. (2022). Microglia states and nomenclature: A field at its crossroads.Neuron, 110(21), 3458\u20133483. https:\/\/doi.org\/10.1016\/j.neuron.2022.10.020","DOI":"10.1016\/j.neuron.2022.10.020"},{"key":"10944_CR53","doi-asserted-by":"publisher","unstructured":"Liu L, Lu Y, Martinez J, Bi Y, Lian G, Wang T, Milasta S, Wang J, Yang M, Liu G, Green DR (2016) Proinflammatory signal suppresses proliferation and shifts macrophage metabolism from Myc-dependent to HIF1 \u03b1-dependent. Proc. Natl. Acad. Sci. U. S. A 113(6):1564-9. https:\/\/doi.org\/10.1073\/pnas.1518000113","DOI":"10.1073\/pnas.1518000113"},{"key":"10944_CR54","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.semcdb.2019.05.004","volume":"94","author":"CS Subhramanyam","year":"2019","unstructured":"Subhramanyam CS, Wang C, Hu Q, Dheen ST (2019) Microglia-mediated neuroinflammation in neurodegenerative diseases. Semin Cell Dev Biol 94:112\u2013120. https:\/\/doi.org\/10.1016\/j.semcdb.2019.05.004","journal-title":"Semin Cell Dev Biol"},{"issue":"7196","key":"10944_CR55","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nature06905","volume":"453","author":"J Rius","year":"2008","unstructured":"Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V, Johnson RS, Haddad GG, Karin M (2008) NF-\u03baB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1\u03b1. Nature 453(7196):807\u2013811. https:\/\/doi.org\/10.1038\/nature06905","journal-title":"Nature"},{"key":"10944_CR56","doi-asserted-by":"publisher","unstructured":"Cheng SC, Quintin J, Cramer RA, Shepardson KM, Saeed S, Kumar V, Giamarellos-Bourboulis EJ, Martens JH, Rao NA, Aghajanirefah A, Manjeri GR (2014) mTOR-and HIF-1\u03b1\u2013mediated aerobic glycolysis as metabolic basis for trained immunity. science 345(6204):1250684. https:\/\/doi.org\/10.1126\/science.1250684","DOI":"10.1126\/science.1250684"},{"key":"10944_CR57","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.cca.2021.08.009","volume":"522","author":"S Latif","year":"2021","unstructured":"Latif S, Jahangeer M, Razia DM, Ashiq M, Ghaffar A, Akram M, El Allam A, Bouyahya A, Garipova L, Shariati MA, Thiruvengadam M (2021) Dopamine in parkinson\u2019s disease. Clin Chim Acta 522:114\u2013126. https:\/\/doi.org\/10.1016\/j.cca.2021.08.009","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10944_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2010.12.017","volume":"508","author":"SC Daubner","year":"2011","unstructured":"Daubner SC, Le T, Wang S (2011) Tyrosine hydroxylase and regulation of dopamine synthesis. ABB 508(1):1\u20132. https:\/\/doi.org\/10.1016\/j.abb.2010.12.017","journal-title":"ABB"},{"issue":"1","key":"10944_CR59","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1471-4159.2010.06917.x","volume":"115","author":"JL Johansen","year":"2010","unstructured":"Johansen JL, Sager TN, Lotharius J, Witten L, M\u00f8rk A, Egebjerg J, Thirstrup K (2010) HIF Prolyl hydroxylase Inhibition increases cell viability and potentiates dopamine release in dopaminergic cells. J Neurochem 115(1):209\u2013219. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06917.x","journal-title":"J Neurochem"},{"issue":"6","key":"10944_CR60","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/WNR.0000000000000356","volume":"26","author":"J Lim","year":"2015","unstructured":"Lim J, Kim HI, Bang Y, Seol W, Choi HS, Choi HJ (2015) Hypoxia-inducible factor-1\u03b1 upregulates tyrosine hydroxylase and dopamine transporter by nuclear receptor ERR\u03b3 in SH-SY5Y cells. NeuroReport 26(6):380\u2013386. https:\/\/doi.org\/10.1097\/WNR.0000000000000356","journal-title":"NeuroReport"},{"issue":"6","key":"10944_CR61","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1523\/JNEUROSCI.18-06-01979.1998","volume":"18","author":"SR Jones","year":"1998","unstructured":"Jones SR, Gainetdinov RR, Wightman RM, Caron MG (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 18(6):1979\u20131986. https:\/\/doi.org\/10.1523\/JNEUROSCI.18-06-01979.1998","journal-title":"J Neurosci"},{"issue":"7","key":"10944_CR62","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1002\/jnr.21988","volume":"87","author":"L Witten","year":"2009","unstructured":"Witten L, Sager T, Thirstrup K, Johansen JL, Larsen DB, Montezinho LP, M\u00f8rk A (2009) HIF Prolyl hydroxylase Inhibition augments dopamine release in the rat brain in vivo. J Neurosci Res 87(7):1686\u20131694. https:\/\/doi.org\/10.1002\/jnr.21988","journal-title":"J Neurosci Res"},{"issue":"2","key":"10944_CR63","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1523\/JNEUROSCI.2482-06.2007","volume":"27","author":"J Milosevic","year":"2007","unstructured":"Milosevic J, Maisel M, Wegner F, Leuchtenberger J, Wenger RH, Gerlach M, Storch A, Schwarz J (2007) Lack of hypoxia-inducible factor-1\u03b1 impairs midbrain neural precursor cells involving vascular endothelial growth factor signaling. J Neurosci 27(2):412\u2013421. https:\/\/doi.org\/10.1523\/JNEUROSCI.2482-06.2007","journal-title":"J Neurosci"},{"key":"10944_CR64","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1093\/emboj\/cdg392","volume":"22","author":"E Berra","year":"2003","unstructured":"Berra E, Benizri E, Ginouv\u00e8s A, Volmat V, Roux D, Pouyss\u00e9gur J (2003) HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady\u2010state levels of HIF\u20101\u03b1 in normoxia. EMBP J 22:4082\u20134090. https:\/\/doi.org\/10.1093\/emboj\/cdg392","journal-title":"EMBP J"},{"issue":"11","key":"10944_CR65","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1002\/jnr.21687","volume":"86","author":"TS Kim","year":"2008","unstructured":"Kim TS, Misumi S, Jung CG, Masuda T, Isobe Y, Furuyama F, Nishino H, Hida H (2008) Increase in dopaminergic neurons from mouse embryonic stem cell-derived neural progenitor\/stem cells is mediated by hypoxia inducible factor\u20101\u03b1. J Neurosci Res 86(11):2353\u20132362. https:\/\/doi.org\/10.1002\/jnr.21687","journal-title":"J Neurosci Res"},{"key":"10944_CR66","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.expneurol.2016.03.016","volume":"280","author":"C Guo","year":"2016","unstructured":"Guo C, Hao LJ, Yang ZH, Chai R, Zhang S, Gu Y, Gao HL, Zhong ML, Wang T, Li JY, Wang ZY (2016) Deferoxamine-mediated up-regulation of HIF-1\u03b1 prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice. Exp Neurol 280:13\u201323. https:\/\/doi.org\/10.1016\/j.expneurol.2016.03.016","journal-title":"Exp Neurol"},{"issue":"1","key":"10944_CR67","doi-asserted-by":"publisher","first-page":"e54296","DOI":"10.1371\/journal.pone.0054296","volume":"8","author":"Y Wang","year":"2013","unstructured":"Wang Y, Yang J, Li H, Wang X, Zhu L, Fan M, Wang X (2013) Hypoxia promotes dopaminergic differentiation of mesenchymal stem cells and shows benefits for transplantation in a rat model of parkinson\u2019s disease. PLoS ONE 8(1):e54296. https:\/\/doi.org\/10.1371\/journal.pone.0054296","journal-title":"PLoS ONE"},{"issue":"3","key":"10944_CR68","doi-asserted-by":"publisher","first-page":"a033993","DOI":"10.1101\/cshperspect.a033993","volume":"12","author":"S Finkbeiner","year":"2020","unstructured":"Finkbeiner S (2020) The autophagy lysosomal pathway and neurodegeneration. Cold Spring Harb Perspect Boil 12(3):a033993. https:\/\/doi.org\/10.1101\/cshperspect.a033993","journal-title":"Cold Spring Harb Perspect Boil"},{"key":"10944_CR69","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.2147\/DDDT.S194182","volume":"9","author":"Y Hou","year":"2019","unstructured":"Hou Y, Wang J, Feng J (2019) The neuroprotective effects of Curcumin are associated with the regulation of the reciprocal function between autophagy and HIF-1\u03b1 in cerebral ischemia-reperfusion injury. Drug Des Dev Ther 9:1135\u20131144. https:\/\/doi.org\/10.2147\/DDDT.S194182","journal-title":"Drug Des Dev Ther"},{"issue":"6","key":"10944_CR70","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1083\/jcb.201003122","volume":"190","author":"AR Winslow","year":"2010","unstructured":"Winslow AR, Chen CW, Corrochano S, Acevedo-Arozena A, Gordon DE, Peden AA, Lichtenberg M, Menzies FM, Ravikumar B, Imarisio S, Brown S (2010) \u03b1-Synuclein impairs macroautophagy: implications for parkinson\u2019s disease. J Cell Biol 190(6):1023\u20131037. https:\/\/doi.org\/10.1083\/jcb.201003122","journal-title":"J Cell Biol"},{"issue":"40","key":"10944_CR71","doi-asserted-by":"publisher","first-page":"34690","DOI":"10.1074\/jbc.M111.261321","volume":"286","author":"S Pemberton","year":"2011","unstructured":"Pemberton S, Madiona K, Pieri L, Kabani M, Bousset L, Melki R (2011) Hsc70 protein interaction with soluble and fibrillar \u03b1-synuclein. JBC 286(40):34690\u201334699. https:\/\/doi.org\/10.1074\/jbc.M111.261321","journal-title":"JBC"},{"issue":"1","key":"10944_CR72","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/s41598-020-58482-w","volume":"10","author":"A Singh","year":"2020","unstructured":"Singh A, Wilson JW, Schofield CJ, Chen R (2020) Hypoxia-inducible factor (HIF) Prolyl hydroxylase inhibitors induce autophagy and have a protective effect in an in-vitro ischaemia model. Sci Rep 10(1):1597. https:\/\/doi.org\/10.1038\/s41598-020-58482-w","journal-title":"Sci Rep"},{"key":"10944_CR73","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s12031-018-1162-7","volume":"66","author":"N Lu","year":"2018","unstructured":"Lu N, Li X, Tan R, An J, Cai Z, Hu X, Wang F, Wang H, Lu C, Lu H (2018) HIF-1\u03b1\/Beclin1-mediated autophagy is involved in neuroprotection induced by hypoxic preconditioning. J Mol Neurosci 66:238\u2013250. https:\/\/doi.org\/10.1007\/s12031-018-1162-7","journal-title":"J Mol Neurosci"},{"issue":"1","key":"10944_CR74","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4161\/auto.8.1.16645","volume":"8","author":"E Wirawan","year":"2012","unstructured":"Wirawan E, Lippens S, Vanden Berghe T, Romagnoli A, Fimia GM, Piacentini M, Vandenabeele P (2012) Beclin1: a role in membrane dynamics and beyond. Autophagy 8(1):6\u201317. https:\/\/doi.org\/10.4161\/auto.8.1.16645","journal-title":"Autophagy"},{"issue":"1","key":"10944_CR75","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/cr.2013.153","volume":"24","author":"AM Cuervo","year":"2014","unstructured":"Cuervo AM, Wong E (2014) Chaperone-mediated autophagy: roles in disease and aging. Cell Res 24(1):92\u2013104. https:\/\/doi.org\/10.1038\/cr.2013.153","journal-title":"Cell Res"},{"issue":"4","key":"10944_CR76","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.neuint.2012.01.020","volume":"60","author":"E Dohi","year":"2012","unstructured":"Dohi E, Tanaka S, Seki T, Miyagi T, Hide I, Takahashi T, Matsumoto M, Sakai N (2012) Hypoxic stress activates chaperone-mediated autophagy and modulates neuronal cell survival. Neurochem Int 60(4):431\u2013442. https:\/\/doi.org\/10.1016\/j.neuint.2012.01.020","journal-title":"Neurochem Int"},{"issue":"2","key":"10944_CR77","doi-asserted-by":"publisher","first-page":"243","DOI":"10.4161\/auto.7.2.14332","volume":"7","author":"ME Gegg","year":"2011","unstructured":"Gegg ME, Schapira AH (2011) PINK1-parkin-dependent mitophagy involves ubiquitination of Mitofusins 1 and 2: implications for Parkinson disease pathogenesis. Autophagy 7(2):243\u2013245. https:\/\/doi.org\/10.4161\/auto.7.2.14332","journal-title":"Autophagy"},{"issue":"7","key":"10944_CR78","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41419-021-03900-8","volume":"12","author":"H Wen","year":"2021","unstructured":"Wen H, Li L, Zhan L, Zuo Y, Li K, Qiu M, Li H, Sun W, Xu E (2021) Hypoxic postconditioning promotes mitophagy against transient global cerebral ischemia via PINK1\/Parkin-induced mitochondrial ubiquitination in adult rats. Cell Death Dis 12(7):630. https:\/\/doi.org\/10.1038\/s41419-021-03900-8","journal-title":"Cell Death Dis"},{"issue":"4587","key":"10944_CR79","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219(4587):979\u2013980. https:\/\/doi.org\/10.1126\/science.6823561","journal-title":"Science"},{"issue":"10","key":"10944_CR80","doi-asserted-by":"publisher","first-page":"6083","DOI":"10.1038\/s41380-021-01207-w","volume":"26","author":"J Magalhaes","year":"2021","unstructured":"Magalhaes J, Tresse E, Ejlerskov P, Hu E, Liu Y, Marin A, Montalant A, Satriano L, Rundsten CF, Carlsen EM, Rydbirk R (2021) PIAS2-mediated Blockade of IFN-\u03b2 signaling: a basis for sporadic Parkinson disease dementia. Mol Psychiatry 26(10):6083\u20136099. https:\/\/doi.org\/10.1038\/s41380-021-01207-w","journal-title":"Mol Psychiatry"},{"issue":"23","key":"10944_CR81","doi-asserted-by":"publisher","first-page":"20710","DOI":"10.1074\/jbc.M110.213538","volume":"286","author":"K Nakamura","year":"2011","unstructured":"Nakamura K, Nemani VM, Azarbal F, Skibinski G, Levy JM, Egami K, Munishkina L, Zhang J, Gardner B, Wakabayashi J, Sesaki H (2011) Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein \u03b1-synuclein. JBC 286(23):20710\u201320726","journal-title":"JBC"},{"key":"10944_CR82","doi-asserted-by":"publisher","unstructured":"Weng M, Xie X, Liu C, Lim KL, Zhang CW, Li L (2018) The sources of reactive oxygen species and its possible role in the pathogenesis of Parkinson\u2019s disease. Parkinson\u2019s disease. 2018(1):9163040. https:\/\/doi.org\/10.1155\/2018\/9163040","DOI":"10.1155\/2018\/9163040"},{"issue":"4","key":"10944_CR83","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s43587-021-00054-2","volume":"1","author":"R March-Diaz","year":"2021","unstructured":"March-Diaz R, Lara-Ure\u00f1a N, Romero-Molina C, Heras-Garvin A, Ortega-de San Luis C, Alvarez-Vergara MI, Sanchez-Garcia MA, Sanchez-Mejias E, Davila JC, Rosales-Nieves AE, Forja C (2021) Hypoxia compromises the mitochondrial metabolism of alzheimer\u2019s disease microglia via HIF1. Nat Aging 1(4):385\u2013399. https:\/\/doi.org\/10.1038\/s43587-021-00054-2","journal-title":"Nat Aging"},{"issue":"1","key":"10944_CR84","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1602\/neurorx.1.1.26","volume":"1","author":"FR Sharp","year":"2004","unstructured":"Sharp FR, Ran R, Lu A, Tang Y, Strauss KI, Glass T, Ardizzone T, Bernaudin M (2004) Hypoxic preconditioning protects against ischemic brain injury. NeuroRx 1(1):26\u201335. https:\/\/doi.org\/10.1602\/neurorx.1.1.26","journal-title":"NeuroRx"},{"issue":"4","key":"10944_CR85","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.tibs.2015.02.003","volume":"40","author":"BJ Ryan","year":"2015","unstructured":"Ryan BJ, Hoek S, Fon EA, Wade-Martins R (2015) Mitochondrial dysfunction and mitophagy in parkinson\u2019s: from Familial to sporadic disease. TIBS 40(4):200\u2013210. https:\/\/doi.org\/10.1016\/j.tibs.2015.02.003","journal-title":"TIBS"},{"key":"10944_CR86","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fnagi.2018.00121","volume":"10","author":"X Li","year":"2018","unstructured":"Li X, Cui XX, Chen YJ, Wu TT, Xu H, Yin H, Wu YC (2018) Therapeutic potential of a Prolyl hydroxylase inhibitor FG-4592 for parkinson\u2019s diseases in vitro and in vivo: regulation of redox biology and mitochondrial function. Front Aging Neurosci 10:121. https:\/\/doi.org\/10.3389\/fnagi.2018.00121","journal-title":"Front Aging Neurosci"},{"issue":"9","key":"10944_CR87","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1523\/JNEUROSCI.5654-07.2008","volume":"28","author":"DR Gutsaeva","year":"2008","unstructured":"Gutsaeva DR, Carraway MS, Suliman HB, Demchenko IT, Shitara H, Yonekawa H, Piantadosi CA (2008) Transient hypoxia stimulates mitochondrial biogenesis in brain subcortex by a neuronal nitric oxide synthase-dependent mechanism. J Neurosci 28(9):2015\u20132024. https:\/\/doi.org\/10.1523\/JNEUROSCI.5654-07.2008","journal-title":"J Neurosci"},{"issue":"1","key":"10944_CR88","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s42466-024-00325-4","volume":"6","author":"G H\u00f6glinger","year":"2024","unstructured":"H\u00f6glinger G, Trenkwalder C (2024) Diagnosis and treatment of parkinson\u00b4 s disease (guideline of the German society for Neurology). Neurol Res Pract 6(1):30. https:\/\/doi.org\/10.1186\/s42466-024-00325-4","journal-title":"Neurol Res Pract"},{"issue":"3","key":"10944_CR89","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.3390\/ijms25031759","volume":"25","author":"J Burtscher","year":"2024","unstructured":"Burtscher J, Duderstadt Y, Gatterer H, Burtscher M, Vozdek R, Millet GP, Hicks AA, Ehrenreich H, Kopp M (2024) Hypoxia sensing and responses in parkinson\u2019s disease. Int J Mol Sci 25(3):1759. https:\/\/doi.org\/10.3390\/ijms25031759","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10944_CR90","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12640-009-9070-9","volume":"17","author":"S Gal","year":"2010","unstructured":"Gal S, Zheng H, Fridkin M, Youdim MB (2010) Restoration of nigrostriatal dopamine neurons in post-MPTP treatment by the novel multifunctional brain-permeable iron chelator-monoamine oxidase inhibitor drug, M30. Neurotox Res 17(1):15\u201327. https:\/\/doi.org\/10.1007\/s12640-009-9070-9","journal-title":"Neurotox Res"},{"key":"10944_CR91","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neulet.2014.07.014","volume":"579","author":"Y Feng","year":"2014","unstructured":"Feng Y, Liu T, Li XQ, Liu Y, Zhu XY, Jankovic J, Pan TH, Wu YC (2014) Neuroprotection by Orexin-A via HIF-1\u03b1 induction in a cellular model of parkinson\u2019s disease. Neurosci Lett 579:35\u201340. https:\/\/doi.org\/10.1016\/j.neulet.2014.07.014","journal-title":"Neurosci Lett"},{"issue":"42","key":"10944_CR92","doi-asserted-by":"publisher","first-page":"29065","DOI":"10.1074\/jbc.M109.000638","volume":"284","author":"DW Lee","year":"2009","unstructured":"Lee DW, Rajagopalan S, Siddiq A, Gwiazda R, Yang L, Beal MF, Ratan RR, Andersen JK (2009) Inhibition of Prolyl hydroxylase protects against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced neurotoxicity: model for the potential involvement of the hypoxia-inducible factor pathway in Parkinson disease. JBC 284(42):29065\u201329076. https:\/\/doi.org\/10.1074\/jbc.M109.000638","journal-title":"JBC"},{"issue":"2","key":"10944_CR93","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.neuropharm.2003.09.005","volume":"46","author":"DB Shachar","year":"2004","unstructured":"Shachar DB, Kahana N, Kampel V, Warshawsky A, Youdim MB (2004) Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats. Neuropharmacology 46(2):254\u2013263. https:\/\/doi.org\/10.1016\/j.neuropharm.2003.09.005","journal-title":"Neuropharmacology"},{"key":"10944_CR94","doi-asserted-by":"publisher","first-page":"104725","DOI":"10.1016\/j.nbd.2019.104725","volume":"136","author":"P Aim\u00e9","year":"2020","unstructured":"Aim\u00e9 P, Karuppagounder SS, Rao A, Chen Y, Burke RE, Ratan RR, Greene LA (2020) The drug adaptaquin blocks ATF4\/CHOP-dependent pro-death Trib3 induction and protects in cellular and mouse models of parkinson\u2019s disease. Neurobiol Dis 136:104725. https:\/\/doi.org\/10.1016\/j.nbd.2019.104725","journal-title":"Neurobiol Dis"},{"key":"10944_CR95","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00726-019-02759-6","volume":"52","author":"N Ferlazzo","year":"2020","unstructured":"Ferlazzo N, Curr\u00f2 M, Giunta ML, Longo D, Rizzo V, Caccamo D, Ientile R (2020) Up-regulation of HIF-1\u03b1 is associated with neuroprotective effects of Agmatine against rotenone-induced toxicity in differentiated SH-SY5Y cells. Amino Acids 52:171\u2013179","journal-title":"Amino Acids"},{"issue":"27","key":"10944_CR96","doi-asserted-by":"publisher","first-page":"8828","DOI":"10.1523\/JNEUROSCI.1779-09.2009","volume":"29","author":"A Siddiq","year":"2009","unstructured":"Siddiq A, Aminova LR, Troy CM, Suh K, Messer Z, Semenza GL, Ratan RR (2009) Selective Inhibition of hypoxia-inducible factor (HIF) prolyl-hydroxylase 1 mediates neuroprotection against normoxic oxidative death via HIF-and CREB-independent pathways. J Neurosci 29(27):8828\u20138838","journal-title":"J Neurosci"},{"key":"10944_CR97","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.expneurol.2013.03.017","volume":"247","author":"F Febbraro","year":"2013","unstructured":"Febbraro F, Andersen KJ, Sanchez-Guajardo V, Tentillier N, Romero-Ramos M (2013) Chronic intranasal deferoxamine ameliorates motor defects and pathology in the \u03b1-synuclein rAAV parkinson\u2019s model. Exp Neurol 247:45\u201358. https:\/\/doi.org\/10.1016\/j.expneurol.2013.03.017","journal-title":"Exp Neurol"},{"key":"10944_CR98","doi-asserted-by":"publisher","first-page":"101090","DOI":"10.1016\/j.redox.2018.101090","volume":"21","author":"SF Xu","year":"2019","unstructured":"Xu SF, Zhang YH, Wang S, Pang ZQ, Fan YG, Li JY, Wang ZY, Guo C (2019) Lactoferrin ameliorates dopaminergic neurodegeneration and motor deficits in MPTP-treated mice. Redox Biol 21:101090. https:\/\/doi.org\/10.1016\/j.redox.2018.101090","journal-title":"Redox Biol"},{"issue":"22","key":"10944_CR99","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1056\/NEJMoa2209254","volume":"387","author":"D Devos","year":"2022","unstructured":"Devos D, Labreuche J, Rascol O, Corvol JC, Duhamel A, Guyon Delannoy P, Poewe W, Compta Y, Pavese N, R\u016f\u017ei\u010dka E, Du\u0161ek P (2022) Trial of deferiprone in parkinson\u2019s disease. NEJM 387(22):2045\u20132055. https:\/\/doi.org\/10.1056\/NEJMoa2209254","journal-title":"NEJM"},{"issue":"1","key":"10944_CR100","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/s41598-017-01402-2","volume":"7","author":"A Martin-Bastida","year":"2017","unstructured":"Martin-Bastida A, Ward RJ, Newbould R, Piccini P, Sharp D, Kabba C, Patel MC, Spino M, Connelly J, Tricta F, Crichton RR (2017) Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in parkinson\u2019s disease. Sci Rep 7(1):1398. https:\/\/doi.org\/10.1038\/s41598-017-01402-2","journal-title":"Sci Rep"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10944-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10944-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10944-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T05:02:46Z","timestamp":1766898166000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10944-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10944"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10944-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"9 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"858"}}